Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P Sirven
CXCR4 Inhibitors Could Benefit to HER2 but Not to Triple-Negative Breast Cancer Patients
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
More Breast Cancer Patients Could Benefit From PARP Inhibitors
Cancer
Cancer Research
Oncology
Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin
Oncotarget
Oncology
Checkpoint Inhibitors in Triple-Negative Breast Cancer (TNBC): Where to Go From Here
Cancer
Cancer Research
Oncology
Alcohol, Smoking, and Risk of Her2-Overexpressing and Triple-Negative Breast Cancer Relative to Estrogen Receptor-Positive Breast Cancer
International Journal of Cancer
Cancer Research
Oncology
Triple-Negative Breast Cancer
Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer
Oncotarget
Oncology
BCT Score Predicts Chemotherapy Benefit in Asian Patients With Hormone Receptor-Positive, HER2-negative, Lymph Node-Negative Breast Cancer
PLoS ONE
Multidisciplinary
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology
SIK2 Restricts Autophagic Flux to Support Triple-Negative Breast Cancer Survival
Molecular and Cellular Biology
Cell Biology
Molecular Biology
